intelligence360
  • About us
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Genome Medical has filed a notice of an exempt offering of securities to raise $75,344,304.00 in New Equity Investment.

Genome Medical has filed a notice of an exempt offering of securities to raise $75,344,304.00 in New Equity Investment.

October 2, 2024 Craig Etkin

According to filings with the U.S. Securities and Exchange Commission, Genome Medical is raising up to $75,344,304.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jill Davies played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Genome Medical
Our mission is to enable a world where everyones health is informed by genetics. As a leading telegenetics care delivery company, we make genetics care accessible and actionable for patients throughout the U.S. and Canada through seven-day a week access to genetic services. We partner with health systems, genetic testing laboratories and biopharmaceutical companies. We accelerate, grow and provide service to their patients by launching genetics programs from the ground up, improving the scale and efficiency of existing genomic medicine programs, and providing genetic expertise and services to support clinical trials and sponsored genetic testing programs. With the largest national network of telehealth genetic counselors averaging 10 years clinical experience We have delivered more than 200,000 genetic counseling encounters, scaling to more than 8,500 patients per month and helping health systems expand network reach to more patients by delivering genetic care to patients anywhere, seven days a week. We are a covered benefit for 130 million people in the U.S. Through our nationwide virtual care delivery model, we provide genetics care to patients when and where it is most convenient, reducing patient wait times from as much as 18 months to one week. We have an extensive team of clinicians, including medical geneticists, genetic counselors, physicians and pharmacists. Our clinical specialties include oncology, reproductive health, cardiology, pediatrics, rare disease and proactive health. .

To learn more about Genome Medical, visit http://www.genomemedical.com/
Genome Medical Linkedin Page: https://www.linkedin.com/company/genome-medical/

Contact:
Jill Davies, Chief Executive Officer
877-688-0992
https://www.linkedin.com/in/jill-davies-b9643a22/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.


Venture Capital
7360, California, Genome Medical, intelligence360, San Francisco, South San Francisco, Venture Capital

Post navigation

NEXT
Geophysical Technology has filed a notice of an exempt offering of securities to raise $20,000,000.00 in New Debt Financing.
PREVIOUS
Four Growers has filed a notice of an exempt offering of securities to raise $9,077,219.00 in New Equity Investment.
Comments are closed.

Categories

Recent Posts

  • Epsilon Industries plans new project in Tuscaloosa, Alabama August 12, 2026
  • Electra plans new project in Springfield, Ohio August 12, 2026
  • BeOne Medicines plans new project in Hopewell, New Jersey August 11, 2026
  • Doncasters plans new project in Auburn, Alabama August 11, 2026

Archives

© 2026   Copyright SI360 Inc. All Rights Reserved.